ARCHIVES

Gene Therapy Hyped By Scientists, Panel Tells NIH; Emphasis Must Be Basic Research

This article is from The Cancer Letter archive.

Vol. 21 No. 48 | December 15, 1995

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Cancer Program Critics Called “Irresponsible,” Demagogues”

March 21, 1975

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013